๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› China
Clinical trial register · China

Studies with a Chinese investigative site

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the register
Recruitment status
Phase
Lead sponsor
Sun Yat-sen University490 Fudan University472 Second Affiliated Hospital, Zhejiang University, School of Medicine404 Peking Union Medical College Hospital282 Ruijin Hospital281
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to
19052 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Active, closed
Gedatolisib Plus Fulvestrant With or Without Palbociclib vs Standard-of-Care for the Treatment of Patients With Advanced or Metastatic HR+/HER2- Breast Cancer (VIKTORIA-1)
NCT05501886Breast Cancer
Celcuity Inc
Phase 3
701
2022-12-08
Recruiting
A Study of QL1706 Combined With Platinum-containing Chemotherapy in Adjuvant Treatment of Stage II-IIIB Non-small Cell Lung Cancer After Complete Surgical Resection.
NCT05487391Carcinoma, Non-Small-Cell Lung
Qilu Pharmaceutical Co., Ltd.
Phase 3
632
Shanghai
2022-12-08
Recruiting
Comparison of Two Stapled Antimesenteric Anastomosis for CD: a Randomized Control Trial Study
NCT05658081Crohn Disease, Recurrence
Jinling Hospital, China
Not applicable
236
Nanjing
2022-12-08
Active, closed
Safety and Immunogenicity of Recombinant Herpes Zoster Vaccine (CHO Cells) in Healthy Subjects Aged 18 Years and Above
NCT05636436Herpes Zoster
MAXVAX Biotechnology Limited Liability Company
Phase 1
132
Xinxiang
2022-12-07
Recruiting
Randomized Controlled Clinical Trial of Hyperthermia and Hydrogen Peroxide 3% in the Treatment of Cutaneous Warts
NCT06812065Warts
First Hospital of China Medical University
Not applicable
300
Shenyang
2022-12-07
Recruiting
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
NCT05579366High Grade Epithelial Ovarian Cancer, High Grade Serous Ovarian Cancer, Primary Peritoneal Carcinoma, Fallopian Tube Cancer
Genmab
Phase 1/2
884
Beijing, Chongqing, Changsha, Nanchang, Changchun, Chengdu, Shanghai, Hangzhou
2022-12-07
Not yet open
Colchicine Use for Primary Prevention of Coronary Artery Disease
NCT05175274Coronary Artery Disease
Qingdao Central Hospital
Phase 3
6,792
Qingdao
2022-12-06
Active, closed
Study of Efficacy and Safety of JDQ443 Single-agent as First-line Treatment for Patients With Locally Advanced or Metastatic KRAS G12C- Mutated Non-small Cell Lung Cancer With a PD-L1 Expression < 1% or a PD-L1 Expression โ‰ฅ 1% and an STK11 Co-mutation.
NCT05445843Locally Advanced or Metastatic KRAS G12C-mutated NSCLC With a PD-L1 Expression <1% or a PD-L1 Expression โ‰ฅ 1% and an STK11 Co-mutation
Novartis Pharmaceuticals
Phase 2
95
Wuhan, Changsha, Beijing
2022-12-06
Active, closed
Study to Evaluate Adverse Events, Change in Disease Activity, and How ABBV-706 Moves Through the Body When Intravenously (IV) Infused Alone or in Combination With IV Infused Budigalimab, Cisplatin, or Carboplatin in Adult Participants With Advanced Solid Tumors
NCT05599984Advanced Solid Tumors
AbbVie
Phase 1
288
Beijing, Wuhan, Shenyang, Shanghai
2022-12-05
Recruiting
Prognosis Prediction System of Patients With Cardiovascular and Cerebrovascular Diseases Based on Multi-omics
NCT06001073Coronary Artery Disease, Arrhythmias, Cardiac, Heart Valve Diseases, Aortic Dissection
First Affiliated Hospital Xi'an Jiaotong University
Observational
25,000
Xi'an
2022-12-05
Active, closed
Anlotinib Combined With Chemotherapy and Neoadjuvant Therapy for Hormone Receptor-positive HER-2 Negative Breast Cancer
NCT05558722Breast Cancer Stage II
Xijing Hospital
Phase 2
31
Xi'an
2022-12-05
Active, closed
A 24-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough
NCT05600777Cough, Refractory Chronic Cough
Bellus Health Inc. - a GSK company
Phase 3
997
Kunshan, Leshan, รœrรผmqi, Beijing, Changsha, Chengdu, Chongqing, Dongguan
2022-12-05
Recruiting
Follow up Study on Visual Prognosis and Complications of Ectopia Lentis Lens
NCT05654025Ectopia Lentis, Dislocation, Lens
Zhongshan Ophthalmic Center, Sun Yat-sen University
Observational
604
Guangzhou
2022-12-05
Active, closed
Effect of Mobile Communication on Congenital Ectopia Lentis Follow-up Adherence
NCT05628129Ectopia Lentis
Zhongshan Ophthalmic Center, Sun Yat-sen University
Not applicable
110
Guangzhou
2022-12-05
Recruiting
Pemigatinib in the Advanced Gastrointestinal Cancer With FGFR 1-3 Alterations
NCT05651672Gastrointestinal Cancer
Tianjin Medical University Cancer Institute and Hospital
Phase 2
100
Tianjin
2022-12-02
Recruiting
Neoadjuvant Camrelizumab Combined With Chemotherapy for Resectable Stage IIIA-IIIB NSCLC
NCT06241807IMMUNOTHERAPY, Neoadjuvant Therapy, Resectable Lung Non-Small Cell Carcinoma, Biomarkers / Blood
Shandong Cancer Hospital and Institute
Phase 2
30
Jinan
2022-12-02
Recruiting
Rituximab, Methotrexate, and Tepadina Induction Followed by Etoposide and Cytarabine Consolidation in Primary Central Nervous System Lymphoma
NCT06946407Primary Central Nervous System Lymphoma (PCNSL), CNS Lymphoma Treatment
FengYan Jin
Not applicable
41
Changchun
2022-12-02
Recruiting
Promotion and Application of a New Three-level Etiological Diagnosis Strategy for Fever Clinics in Respiratory Infectious Diseases
NCT05965128Respiratory Infectious Diseases
Huashan Hospital
Observational
1,255
Lanzhou, Harbin, Hohhot, Suzhou, Xuzhou, Shenyang, Jinan, Jining
2022-12-01
Recruiting
Clinical Study of PSMA-targeted CAR-T Cells in the Treatment of Castration-resistant Prostate Cancer
NCT05354375Immunotherapy
The Affiliated Hospital of Xuzhou Medical University
Phase 1
20
Xuzhou
2022-12-01
Recruiting
VCA Regimen Followed by D-MAG Regimen on the Treatment of Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)
NCT05603884Leukemia, Myeloid, Acute, AML Stage, Adult
The First Affiliated Hospital of Xiamen University
Phase 2
66
Xiamen
2022-12-01
Recruiting
Fecal Microbiota Transplantation in Pediatric Ulcerative Colitis (UC)
NCT05679622Ulcerative Colitis
Biao Zou
Not applicable
30
Wuhan
2022-12-01
Recruiting
Concurrent and Adjuvant Nimotuzumab Combined With Induction Chemotherapy Plus Chemoradiation in Nasopharyngeal Carcinoma
NCT05717790Nasopharyngeal Carcinoma by AJCC V8 Stage
Fourth Affiliated Hospital of Guangxi Medical University
Not applicable
288
Baise City, Guilin, Liuzhou, Nanjing, Qinzhou, Wuzhou
2022-12-01
Not yet open
Radiogenomics in Glioblastoma: Correlation Between Multiparametric Imaging Biomarkers and Genetic Biomarkers
NCT05541042Glioblastoma
Henan Provincial People's Hospital
Observational
50
Zhengzhou
2022-12-01
Recruiting
A Study on Diagnosis and Treatment Strategies for Atlantoaxial Dislocation
NCT06233539Atlantoaxial Dislocation, Treatment, Diagnostic
Peking University Third Hospital
Observational
3,000
Beijing
2022-12-01
Recruiting
A Study on Relationship Between Resected Normal Liver Parenchymal Volume๏ผˆRNLV๏ผ‰and Post-Hepatectomy Liver Failure (PHLF)
NCT06366048Liver Failure
National Natural Science Foundation of China
Observational
1,600
Fujian, Shanhai, Shenzhencun
2022-12-01
Not yet open
Cytoreductive Surgery in Platinum-resistant Recurrent Ovarian Cancer
NCT05633199Cytoreductive Surgery
Women's Hospital School Of Medicine Zhejiang University
Not applicable
140
Hangzhou
2022-12-01
Recruiting
Xian-Lian-Jie-Du Optimization Decoction As an Adjuvant Treatment for Prevention of Recurrence of Colon Cancer
NCT05709249Colon Cancer
Jiangsu Famous Medical Technology Co., Ltd.
Phase 3
730
Nanjing
2022-12-01
Active, closed
To Explore the Influencing Factors and Solutions for Patients With Plaque Psoriasis Undergoing Relapse
NCT07730619Plaque Psoriasis, Biologic Agents, Relapse, Influence Factors
First Affiliated Hospital Xi'an Jiaotong University
Observational
140
Xi'an
2022-12-01
Recruiting
TIPS Plus Cadonilimab in Advanced HCC with Tumor Thrombosis-associated Portal Hypertension:a Prospective, Single-arm, Phase II Study
NCT05882370Hepatocellular Carcinoma
Fei Gao
Phase 2
30
Guangzhou
2022-12-01
Not yet open
Sintilimab (One Anti-PD-1 Antibody) Plus Low-dose Bevacizumab for ctDNAlevel- Relapse and Clinical-relapse Astrocytoma
NCT05518994Astrocytoma of Brain
Henan Provincial People's Hospital
Phase 2
70
Zhengzhou
2022-12-01
Recruiting
Deep Enhanced Imaging in Stroke and Vascular Neurology
NCT05614193Radiology, Cerebral Stroke, Vascular Diseases
Chinese PLA General Hospital
Observational
1,000
Beijing
2022-12-01
Recruiting
Pharmacogenetics-Based Study on Individualized Use of Sodium Valproate
NCT07046676Epilepsy
The First Affiliated Hospital of University of South China
Phase 4
312
Hengyang
2022-12-01
Active, closed
Exploring the Effect of Colonic J-pouch in Anorectal Preservation Surgery for Ultra-low Rectal Cancer.
NCT06601985Rectum Cancer, Faecal Incontinence, Faecal Incontinence with Faecal Urgency, Low Anterior Resection Syndrome
Shanghai 10th People's Hospital
Observational
154
Shanghai
2022-12-01
Recruiting
Intelligent Diagnosis and Treatment Model for Insomnia Disorder
NCT06375447Insomnia
Xuanwu Hospital, Beijing
Observational
16,000
Beijing, Changchun, Chengdu, Suzhou
2022-12-01
Active, closed
Serplulimab Combined With Chemotherapy in Patients With Resectable Esophageal Squamous Cell Carcinoma
NCT05659251Esophageal Squamous Cell Carcinoma, Neoadjuvant Therapy
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 2
48
Hangzhou
2022-12-01
Not yet open
Genetic and Epigenetic Determinants of Response to Fluorouracil-based Adjuvant Chemotherapy in Patients With Stage III Colorectal Cancer
NCT03127111Stage III Colorectal Cancer
Renmin Hospital of Wuhan University
Observational
300
Wuhan
2022-12-01
Not yet open
A Combination Therapy Including Anti-PD-1 Immunotherapy in MSS Rectal Cancer With Resectable Distal Metastasis
NCT05359393Advanced Rectal Cancer, Liver Metastasis, Pulmonary Metastasis, Microsatellite Stable Colorectal Carcinoma
Fudan University
Phase 2
52
Shanghai
2022-12-01
Not yet open
Study of Acupuncture in the Treatment of Hot Flashes in Patients With Hormone Receptor-positive Breast Cancer.
NCT05613504Hot Flashes, Breast Cancer, Acupuncture
Nanjing University of Traditional Chinese Medicine
Not applicable
90
Nanjing
2022-12-01
Recruiting
Construction of a Database for TMA
NCT05634928Thrombotic Microangiopathies
The First Affiliated Hospital of Soochow University
Observational
500
Suzhou
2022-12-01
Recruiting
Clinical Outcomes of HBeAg-negative CHB Patients With Indeterminate Phase
NCT05661786Chronic Hepatitis b
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Observational
4,500
Changzhou, Huai'an, Nanjing, Suqian, Suzhou
2022-12
Recruiting
CD19 CAR-T Expressing IL-7 and CCL19 Combined With Anti-PD1 in RR-DLBCL
NCT05659628Diffuse Large B-cell Lymphoma
Ningbo No. 1 Hospital
Phase 1
24
Hangzhou, Ningbo
2022-12
Recruiting
The Combination of Hypofractionated Radiotherapy and Immunotherapy in Locally Recurrent Rectal Cancer
NCT05628038Recurrent Rectal Cancer
Fudan University
Phase 2
93
Shanghai
2022-11-30
Recruiting
Gene Therapy in Subjects With Biallelic RPE65 Mutation-associated Retinal Dystrophy
NCT05858983Biallelic RPE65 Mutation-associated Retinal Dystrophy
Frontera Therapeutics
Phase 1/2
9
Beijing
2022-11-30
Not yet open
A Multicenter Randomized Controlled Clinical Study on the Treatment of T3N1M0 High Risk Nasopharyngeal Carcinoma With or Without Induction Chemotherapy Before Concurrent Radiotherapy and Chemotherapy
NCT05622474Nasopharyngeal Carcinoma
Sun Yat-sen University
Not applicable
236
Guangzhou
2022-11-30
Recruiting
Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of BAT8008 for Injection
NCT05620017Advanced Solid Tumors
Bio-Thera Solutions
Phase 1
182
Chongqing, Hangzhou
2022-11-30
Active, closed
SKB264 Monotherapy in Selected Subjects With Advanced Solid Tumors
NCT05631262Selected Subjects With Advanced Solid Tumors
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Phase 2
321
Guangzhou
2022-11-30
Active, closed
A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid Tumors
NCT05538130Melanoma, Glioma, Thyroid Cancer, Non-Small Cell Lung Cancer
Pfizer
Phase 1
148
Hangzhou, Wenzhou
2022-11-30
Active, closed
A Study of Dato-DXd With or Without Durvalumab Versus Investigator's Choice of Therapy in Patients With Stage I-III Triple-negative Breast Cancer Without Pathological Complete Response Following Neoadjuvant Therapy (TROPION-Breast03)
NCT05629585Breast Cancer
AstraZeneca
Phase 3
1,174
Beijing, Bengbu, Changchun, Changsha, Chengdu, Chongqing, Fuzhou, Guangzhou
2022-11-28
Recruiting
Artificial Intelligence System for Early Warning of Adverse Events in Acute Myocardial Infarction
NCT07139860Acute Myocardial Infarction With ST Elevation, Intelligent Management Platform, Early Warning
Hui Chen
Observational
1,400
Beijing
2022-11-26
Recruiting
Zanubrutinib Combined With R-CHOP in the Treatment of Newly Diagnosed DLBCL With p53 Protein Expression
NCT06005870Diffuse Large B Cell Lymphoma
Huazhong University of Science and Technology
Phase 2
41
Wuhan
2022-11-26
Active, closed
To Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of KP104
NCT05476887Paroxysmal Nocturnal Hemoglobinuria
Kira Pharmacenticals (US), LLC.
Phase 2
35
Beijing, Nanjing, Tianjin, Zhengzhou
2022-11-25
Active, closed
Dose-finding Study of SAR443122 in Adult Participants With Ulcerative Colitis
NCT05588843Colitis Ulcerative
Sanofi
Phase 2
187
Guangzhou, Hangzhou, Hefei, Nanchang, Nanjing, Shanghai, Shenyang
2022-11-25
Recruiting
The Registry Study of Genetic Alterations of Oropharyngeal Cancer in Taiwan
NCT05522881Oropharyngeal Squamous Cell Carcinoma
National Health Research Institutes, Taiwan
Observational
410
2022-11-25
Active, closed
SBRT Combined With PD-1 Antibody and Chemotherapy in Oligometastatic Nasopharyngeal Carcinoma
NCT05524168Nasopharyngeal Carcinoma
Sun Yat-sen University
Phase 2
41
Guangzhou
2022-11-25
Recruiting
Safety and Efficacy of the GeminiOne Transcatheter Valve Edge-to-Edge Repair System in Patients With Moderate-severe or Severe Degenerative Mitral Regurgitation
NCT05655897Mitral Regurgitation, Degenerative Mitral Valve Disease
Peijia Medical Technology (Suzhou) Co., Ltd.
Not applicable
120
Suzhou
2022-11-24
Active, closed
A Study Evaluating Cadonilimab Injection in Combination With Regorafenib for the Advanced Hepatocellular Carcinoma
NCT05644379Advanced Hepatocellular Carcinoma That Has Failed at Least One Prior Systemic Therapy
Tianjin Medical University Cancer Institute and Hospital
Phase 1
30
Tianjin
2022-11-24
Recruiting
A Study of RC48-ADC Combined with JS001 for Postoperative Adjuvant Treatment of Upper Tract Urothelial Carcinoma
NCT05917158Carcinoma, Upper Tract Urothelial Carcinoma, UTUC
Jinling Hospital, China
Phase 2
30
Nanjing
2022-11-23
Recruiting
Cold Dissection Versus Electrocautery Dissection in Endoscopic Nipple-Sparing Mastectomy and Immediate Implant-Based Reconstruction: A Randomized Controlled Trial
NCT06024187Breast Neoplasms
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Not applicable
566
Guangzhou
2022-11-23
Recruiting
A Study of SHR-1501 Alone or in Combination With BCG or SHR-1316 in Subjects With NMIBC
NCT05410730High-risk NMIBC
Shanghai Hengrui Pharmaceutical Co., Ltd.
Phase 1/2
150
Beijing
2022-11-23
Active, closed
A Study to Evaluate MORF-057 in Adults With Moderately to Severely Active UC
NCT05611671Inflammatory Bowel Diseases, Colitis, Ulcerative
Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)
Phase 2
280
2022-11-21
Active, closed
Safety and Efficacy of ALXN1720 in Adults With Generalized Myasthenia Gravis
NCT05556096Generalized Myasthenia Gravis
Alexion Pharmaceuticals, Inc.
Phase 3
260
Beijing, Changchun, Changsha, Chengdu, Fuzhou, Hangzhou, Jinan, Qingdao
2022-11-21
Active, closed
A Study to Assess Safety, Tolerability and Efficacy of Garetosmab Versus Placebo Administered Intravenously (IV) in Adult Participants With Fibrodysplasia Ossificans Progressiva (FOP)
NCT05394116Fibrodysplasia Ossificans Progressiva
Regeneron Pharmaceuticals
Phase 3
63
Shanghai
2022-11-21
Active, closed
Compression Therapy as a Prophylactic Method Against CIPN: a Prospective Self-controlled Trial
NCT05531916Nasopharyngeal Carcinoma, CIPN - Chemotherapy-Induced Peripheral Neuropathy
Sun Yat-sen University
Not applicable
182
Guangzhou
2022-11-21
Recruiting
Effects and Safety of Diabetic GUideline Algorithm Implementation Performed by Primary Care Physicians in the Community
NCT05349955Type 2 Diabetes, Cardiovascular Complication, Diabetic Kidney Disease
Shanghai Zhongshan Hospital
Not applicable
5,600
Suzhou
2022-11-21
Recruiting
Laparoscopic Gastrectomy With D2 Lymphadenectomy Combined With Hyperthermic Intraperitoneal Chemotherapy (HIPEC) or Not
NCT05871099Gastric Cancer
The Affiliated Hospital of Qingdao University
Phase 3
616
Qingdao
2022-11-20
Recruiting
The Effect of Eyeliner on Tear Composition, Tear Secretion and Tear Film Stability.
NCT05632887Dry Eye
Zhongnan Hospital
Observational
80
Wuhan
2022-11-20
Active, closed
Primary Cervical Cancer Screening by Self-sampling HPV Test
NCT05613283Human Papillomavirus Infection, Cervical Cancer, Negative For Intraepithelial Lesion Or Malignancy, Atypical Squamous Cells of Undetermined Significance
Peking University People's Hospital
Observational
17,875
Beijing, Zhengzhou, Changsha, Chengdu, Hangzhou
2022-11-19
Active, closed
Repeated Low-Level Red-Light Therapy for Shortening Axial Length
NCT05550740High Myopia, Refractive Errors, Eye Diseases
Shanghai Eye Disease Prevention and Treatment Center
Not applicable
30
Shanghai
2022-11-19
Active, closed
Digital Therapy for Fatty Liver Disease
NCT07007741Steatohepatitis, Nonalcoholic, Nonalcoholic Fatty Liver
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Not applicable
141
Shanghai
2022-11-19
Recruiting
C2 Esophageal Squamous Epithelium Dysplasia
NCT05349240Esophageal Squamous Epithelium Dysplasia
Pentax Medical
Not applicable
129
Beijing, Changchun, Changzhi, Shijiazhuang
2022-11-18
Recruiting
Arthroscopic Anterior Cruciate Ligament Repair Versus Reconstruction for Acute Anterior Cruciate Ligament Injury
NCT05584020Anterior Cruciate Ligament Injuries
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
140
Hangzhou
2022-11-18
Recruiting
A Study of WX390 Combined With Toripalimab in Patients With Advanced Solid Tumors
NCT06117566Solid Tumor
Shanghai Jiatan Pharmatech Co., Ltd
Phase 1/2
100
Changchun
2022-11-18
Recruiting
A Study to Evaluate Glofitamab Monotherapy and Glofitamab + Chemoimmunotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Mature B-Cell Non-Hodgkin Lymphoma
NCT05533775Mature B-Cell Non-Hodgkin Lymphoma
Hoffmann-La Roche
Phase 1/2
65
Chengdu, Guangzhou, Nanning
2022-11-16
Recruiting
A Study of ICP-192 in Patients With FGFR2-Rearranged Unresectable or Metastatic Intrahepatic Cholangiocarcinoma
NCT05678270Intrahepatic Cholangiocarcinoma (ICC)
Beijing InnoCare Pharma Tech Co., Ltd.
Phase 2
70
Hefei, Beijing, Fujian, Fuzhou, Foshan, Guangzhou, Shijiazhuang, Harbin
2022-11-15
Recruiting
Study of ZGGS18 in Patients With Advanced Solid Tumors
NCT05584800Advanced Solid Tumor
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Phase 1/2
222
Beijing
2022-11-15
Active, closed
Savolitinib Combine With Durvalumab in EGFR Wild-type Locally Advanced or Metastatic NSCLC
NCT05374603Lung Cancer
AstraZeneca
Phase 2
47
Beijing, Changsha, Chongqing, Hangzhou, Jinan, Kunming, Nanchang, Ningbo
2022-11-15
Active, closed
Transapical Beating-Heart Septal Myectomy for Symptomatic Nonobstructive Hypertrophic Cardiomyopathy
NCT05648825Nonobstructive Hypertrophic Cardiomyopathy
Xiang Wei
Not applicable
100
Wuhan
2022-11-15
Active, closed
Study of Retinfanlimab in Combination With INCAGN02385 and INCAGN02390 as First-Line Treatment in Participants With PD-L1-Positive (CPS โ‰ฅ 1) Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck
NCT05287113Head and Neck Cancer
Incyte Biosciences International Sร rl
Phase 2
176
2022-11-14
Recruiting
A Study of C-CAR088 in Patients With Relapsed or Refractory Multiple Myeloma
NCT05521802Multiple Myeloma
Shanghai AbelZeta Ltd.
Phase 1/2
92
Tianjin
2022-11-11
Recruiting
Study of NY-ESO-1 TCR-T in Advanced Soft Tissue Sarcoma
NCT05620693Advanced Soft-tissue Sarcoma
Shenzhen University General Hospital
Not applicable
20
Shenzhen
2022-11-11
Recruiting
Neoadjuvant Therapy of Sintilimab Combined With Chemotherapy for Resectable Squamous Cell NSCLC๏ผˆneoSCORE โ…ก๏ผ‰
NCT05429463Squamous Cell Non-small Cell Lung Cancer
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 3
250
Hangzhou
2022-11-11
Recruiting
Induction Chemotherapy Followed by IMRT or Concurrent Chemoradiotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma
NCT05527470Nasopharyngeal Carcinoma
Wei Jiang
Phase 3
440
Guilin, Wuzhou
2022-11-11
Recruiting
A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer
NCT05498428Carcinoma, Non-small-Cell Lung
Janssen Research & Development, LLC
Phase 2
520
Baoding, Changchun, Chengdu, Chongqing, Guangzhou, Hangzhou, Harbin, Huizhou
2022-11-11
Recruiting
Study on the Role and Mechanism of Plasma Exosome microRNAs in Cognitive Impairment in First-episode Schizophrenia
NCT07139171Schizophrenia
Tianjin Anding Hospital
Observational
300
Tianjin
2022-11-11
Recruiting
Evaluation and Prediction of the Effect of EECP on HR-NICE Patients
NCT05718622Stroke, Ischemic
First Affiliated Hospital Xi'an Jiaotong University
Not applicable
100
Xi'an
2022-11-10
Recruiting
A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant
NCT05623020Multiple Myeloma
Pfizer
Phase 3
1,116
Beijing, Fuzhou, Guangzhou, Wuhan, Nanjing, Suzhou, Changchun, Shanghai
2022-11-10
Active, closed
Efficacy and Safety of Tezepelumab in Patients With Eosinophilic Esophagitis
NCT05583227Eosinophilic Esophagitis
AstraZeneca
Phase 3
368
Beijing, Guangzhou, Hangzhou, Nanjing, Shanghai, Shenyang, Tianjin, Wuhan
2022-11-10
Active, closed
AK112 in Advanced Non-Small Cell Lung Cancer
NCT05499390Advanced Non-small-cell Lung Cancer
Akeso
Phase 3
398
Shanghai
2022-11-09
Recruiting
A Study of Jincaopian Tablets on Chronic Pelvic Pain After Pelvic Inflammatory Disease
NCT05970783Chronic Pelvic Pain
Beijing Konruns Pharmaceutical Co., Ltd.
Phase 3
414
Beijing
2022-11-08
Active, closed
Study of Purinostat Mesylate for Injection in the Treatment of Relapsed or Refractory Diffuse Large B-cell Lymphoma (R/R DLBCL)
NCT05563844Diffuse Large B Cell Lymphoma๏ผŒDLBCL
Chengdu Zenitar Biomedical Technology Co., Ltd
Phase 2
74
Shanghai, Chengdu
2022-11-08
Active, closed
Phase II Study of Hemay005 in Patients With Active Ulcerative Colitis
NCT05486104Moderate to Severe Ulcerative Colitis
Ganzhou Hemay Pharmaceutical Co., Ltd
Phase 2
92
Hefei, Fuzhou, Guangzhou, Zhengzhou, Wuhan, Changsha, Nanchang, Shenyang
2022-11-08
Active, closed
A Comparison of Contact Aspiration Versus Stent Retriever for Acute Basilar Artery Occlusion
NCT05615038Basilar Artery Occlusion, Endovascular Treatment
Beijing Tiantan Hospital
Not applicable
338
Hefei, Beijing, Anyang, Zhangzhou, Baotou
2022-11-07
Active, closed
Pamiparib Combined With Surufatinib for the Neoadjuvant Treatment of Unresectable Ovarian Cancer
NCT05652283Ovarian Cancer
Bai-Rong Xia
Phase 2
37
Hefei
2022-11-06
Active, closed
Phase III Clinical Trial of 13-valent Pneumococcal Conjugate Vaccine (Multivalent Conjugate) in Infants
NCT05759520Streptococcus Pneumoniae Infection
Fosun Adgenvax Biopharmaceutical Co.,Ltd.
Phase 3
1,800
Hechi, Hezhou, Liuzhou, Nanning
2022-11-04
Active, closed
A First-in-human Study to Learn How Safe the Study Drug BAY2965501 is, Find the Best Dose (Single Drug & Combination), How it Affects the Body, What Maximum Amount Can be Given, How it Moves Into, Through and Out of the Body, How it Acts on Different Tumors in Participants With Advanced Solid Tumors
NCT05614102Advanced Solid Tumors
Bayer
Phase 1
284
Beijing, Shenzhen, Hangzhou
2022-11-04
Recruiting
Large Artery Occlusion Treated in Extended Time With Mechanical Thrombectomy Trial
NCT05326932Acute Ischemic Stroke
Fudan University
Not applicable
336
Shanghai
2022-11-03
Recruiting
Lenvatinib+Sintilimab+TACE vs. Lenvatinib+TACE for Advanced HCC
NCT05608200Hepatocellular Carcinoma Non-resectable
Second Affiliated Hospital of Guangzhou Medical University
Phase 3
427
Guangzhou
2022-11-02
Recruiting
Lenvatinib Plus I-125 Seed Brachytherapy vs. Lenvatinib for TACE-refractory HCC
NCT05608213Hepatocellular Carcinoma Non-resectable
Second Affiliated Hospital of Guangzhou Medical University
Phase 3
187
Guangzhou
2022-11-02
Active, closed
Chemoradiotherapy Following Immunotherapy Plus Chemotherapy for Locally-advanced Esophageal Squamous Cell Cancer (RICE)
NCT05621707Esophageal Squamous Cell Carcinomas, Concurrent Chemoradiotherapy, Immunotherapy, Chemotherapy
Shanghai Chest Hospital
Phase 2
50
Shanghai
2022-11-02
Active, closed
Safety and Efficacy Evaluation of BRL-101 in Subjects With Transfusion-Dependent ฮฒ-Thalassemia
NCT05577312Beta-Thalassemia
Bioray Laboratories
Phase 1/2
39
Guangzhou, Guanzhou, Shenzhen, Nanning, Changsha, Tianjin
2022-11-02
Rows per page Showing 16001–16100 of 19052
Previous 159 160 161 162 163 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site. Derived from ClinicalTrials.gov. Retrieved 22 September 2026. https://priyalifescience.com/clinical-trials-china?page=161

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.